Physician profile
David W Wimberley
NPI 1023006491
$2,205,502.65
in general payments reported to CMS, 2019-2025
17 companies · $207K in 2025
The $207K reported for 2025 was more than what 96% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $470K · 2020: $480K · 2021: $358K · 2022: $271K · 2023: $239K · 2024: $180K · 2025: $207K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $601K · Consulting Fee: $12K · Travel and Lodging: $9,491 · Food and Beverage: $3,806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $601,444.26 |
| Consulting Fee | $11,502.25 |
| Travel and Lodging | $9,491.16 |
| Food and Beverage | $3,805.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $1,608,729.52 | 2019-2025 | Synfix Evolution |
| Alphatec Spine, INC | $547,288.53 | 2019-2025 | Arsenal Degenerative, Other - Miscellaneous, Invictus Open |
| Aesculap Implant Systems, LLC | $30,964.22 | 2019-2022 | |
| Medical Device Business Services, INC. | $10,752.05 | 2023-2024 | Synfix Evolution |
| Globus Medical, INC. | $3,938.76 | 2025 | Excelsius Gps, Creo, Senza |
| Highridge Medical LLC | $1,149.74 | 2025 | Vital, Mobi-C Plug & Fit US, Spine-None |
| Cerapedics INC. | $860.96 | 2022-2025 | I-Factor Peptide Enhanced Bone Graft |
| Horizon Therapeutics Plc | $522.58 | 2019-2022 | |
| Depuy Synthes Sales INC. | $412.89 | 2019-2024 | Acf, Conduit |
| Spinal Elements, INC. | $244.59 | 2024-2025 | |
| Ebi, LLC | $200.00 | 2025 | |
| Medtronic, INC. | $130.29 | 2022 | |
| Zimmer Biomet Holdings, INC. | $119.75 | 2019 | |
| Intrinsic Therapeutics | $77.34 | 2025 | Barricaid Acd (Annular Closure Device) |
| Providence Medical Technology, INC. | $54.06 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alafair Biosciences, INC. | $35.85 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $21.52 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wimberley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.